The Business Journals

Lab Notes: Philadelphia health care investment firm closes two funds valued at over $500M

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min This week's roundup of life ...

Biotech stocks are losing momentum despite rising M&A activity

After strong gains last year, biotech stocks are underperforming YTD despite a record wave of M&A activity fueled in part by ...
FierceBiotech

Ambit joins biotech IPO queue, seeks $58M as AML drug nears PhIII

Now that a window has finally opened on Wall Street for biotech IPOs, a lineup of drug developers are taking their chances and jumping through. The latest to join the queue is Ambit Biosciences, which ...
Seeking Alpha

Core Biotech #30: Assorted Healthcare Conference Notes

Welcome to another edition of Core Biotech!I started this portfolio with the objective of proving that Long-Term investing in the biotech sector is a worthwhile endeavor.New buys and sells are ...
The Business Journals

Lab Notes: Janssen Biotech signs multimillion-dollar cell therapy collaboration and licensing deal

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min This week's life sciences ...